An open-label randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury

An open-label randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury Chinese Journal of Antituberculosis . 2016, (1): 23 -31 . DOI: 10.3969/j.issn.1000-6621.2016.01.007